SAYPHA VOLUME PLUS LIDO (1x1ml) CROMA
zoom_out_map
chevron_left chevron_right
-5%

SAYPHA VOLUME PLUS LIDO (1x1ml) CROMA

SAYPHA VOLUME PLUS LIDOCAINE is a volumetric HA treatment for severe and deep facial wrinkles, loss of volume and improvement of facial contours. RESTORING AND RESHAPING. Skin regains its vitality, firmness and glowing youthful energy. Intensely cross-linked BDDE 4/4 Hyaluronic acid gel 25 mg/ml + lidocain 0,3%.

Quantity Discount You Save
10 5% Up to €32.78
€65.55 (tax incl.) €69.00 -5% €65.55 (tax excl.)
Tax excluded

Description

SAYPHA VOLUME PLUS LIDO (1x1ml)/EX PRINCESS VOLUME PLUS LIDO (1x1ml) CROMA

IN 2019 CROMA PRINCESS BECOMES CROMA SAYPHA. MEDICALE USE. CE Marked Medical Device class III. 

DESCRIPTION

SAYPHA VOLUME PLUS LIDOCAINE is a monophasic, highly-cross linked gel implant, based on hyaluronic acid of non-animal origin. Dermal wrinkle filler with highly cross-linked, sterile, viscoelastic, biodegradable, monophasic hyaluronic acid gel used in advanced treatments. A clear, colourless, isotonic and homogenized injectable gel implant. SAYPHA VOLUME PLUS LIDOCAINE is injected in the deep dermis with a 27G 1/2 needle, it is available with or without the addition of lidocaine for additional comfort during treatment. SMART TECHNOLOGY a unique method of cross–linking created by CROMA.

SAYPHA VOLUME PLUS LIDOCAINE by CROMA DETAILS

  • Concentration HA : 2.5 % (25 mg/mL).
  • Reticulating agent : BDDE 4/4.
  • Other ingredients : Phosphate-buffer, NaCI.
  • Dynamic viscosity (at shear rate 2 s-1: ) : 90.000 – 135.000 mPa.s.
  • Needle : 2 x 27G 1⁄2 thin-wall needles.
  • Packaging : Box of 1 mL syringe.
  • Injection area : Deep dermis or subcutis.
  • Indication : Viscoelastic solution for the correction of deep wrinkles and folds, to increase or restore facial volume, and to shape the facial contours.
  • Estimated duration in the skin: 6 to 12 months.

PROPERTIES

  • Very high elasticity and ability to increase the skin volume.
  • It consists of cross-linked hyaluronic acid, formulated to a concentration of 25 mg/ml in a physiologic buffer.
  • Contains lidocain, a powerful anaesthetic for comfort injection.

INDICATION

  • For severe facial wrinkles, loss of volume and improvement of facial contours.
  • To augment facial tissue and correct midface volume deficit.
  • To restore facial volume and shape the contours of the face.
  • To address reconsytructive purposes in the treatment, for instance, of facial lipoatrophy.
  • RESTORING VOLUMIZING AND RESHAPING. Hyaluronic acid is the key ingredient in SAYPHA VOLUME PLUS LIDOCAINE to eradicate wrinkles by increasing the volume within the skin tissue.
  • SAYPHA VOLUME PLUS LIDOCAINE is indicated for the correction of deep wrinkles and folds, cutaneous depressions, facial contours and the creation of volume. Deep and volumetric treatments.

SECURITY

All products are made from non-animal hyaluronic acid and are manufactured to the highest standards of quality and safety.

COMPOSITION

Intensely cross-linked degree 4/4 Hyaluronic acid BDDE 2.5 % (25 mg/mL) + Lidocaine 0,3% :

  • Cross-linked hyaluronic acid, formulated to a concentration of 25 mg/ml in a physiologic buffer.
  • Level of cross-linking 4/4.
  • Cross-linking agent : BDDE (14%).
  • Lidocaine : 0,3%.
  • OPTIMAL SKIN-TOLERANCE by use of non-animal hyaluronic acid.

PACKAGING

  • 1 x 1ml : Box of 1 ml pre-filled syringe.
  • Needles : 2 X 27 G1/2 thin wall Terumo needles ( CE 0197).
  • Two traceability labels.

INJECTION DEPTH

Injected in the deep dermis or subcutis.

AREA INJECTION

  • Temple, cheeks, nasolabial folds, chin, marionette lines, the mandibular line.
  • Smoothing out of deep face wrinkles and folds, reconstruction of lost volume, efficient method of cheek filling, filling deep skin depressions, correction of sunken temples, restore the natural volumetric, face contour adjustment (cheeks, chin), facial modeling (the area of the temple, cheeks, nasolabial folds, chin, marionette lines, the mandibular line).
  • Lost volume restoration. Facial modelling and contour reshaping.

DURATION

6 to 12 months.

RESULTS

  • SAYPHA VOLUME PLUS LIDOCAINE enables effective face modeling with visible, long-lasting and natural-looking results.
  • Skin regains its vitality, firmness and glowing youthful energy.

SAYPHA® Croma's range of hyaluronic acid fillers includes 6 products:

  • SAYPHA RICH,
  • SAYPHA FILLER (with / without lidocaine),
  • SAYPHA VOLUME (with / without lidocaine) and
  • SAYPHA VOLUME PLUS Lidocaine.

SAYPHA RICH 

  • Regenerates the loss of hyaluronic acid due to aging, improves hydration, skin tone and elasticity and corrects fine lines.
  • The product is injected into the superficial dermal layer.

SAYPHA FILLER and SAYPHA FILLER Lidocaine 

  • Corrects moderate to severe wrinkles and facial wrinkles and increases lip volume (only applicable for SAYPHA FILLER Lidocaine).
  • The product is injected into the intermediate to deep dermis.

SAYPHA VOLUME and SAYPHA VOLUME Lidocaine

  • Have been developed to correct deeper wrinkles and wrinkles and to restore facial volume / reshape facial contours.
  • The product is injected into the deeper skin layer deep dermis or hypodermis.

SAYPHA VOLUME PLUS Lidocaine

  • Is used for facial tissue augmentation to correct lowering of the volume of the middle part of the face and to define the contours of the face as well as for reconstruction purposes, for example in the treatment of facial lipoatrophy.
  • The product is injected subcutaneously, locally or in the deep dermis.
  • All products are made from non-animal hyaluronic acid and are manufactured to the highest standards of quality and safety.

CROMA Pharma GmbH

Founded in 1976, CROMA-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid for the fields of aesthetic medicine, ophthalmology and orthopedics. CROMA currently manages 12 international sales companies and distributes its products in more than 70 countries. In its global sales network, CROMA focuses on its own brand products for minimally invasive cosmetic medicine. In addition to a wide range of hyaluronic acid-based fillers from its own production site, CROMA markets PDO tensor yarns, a Platelet Rich Plasma System (PRP) and customized skin care technology. within its core strategic markets.

Data sheet

0.08 kg
30049000

You might also like